B. Braun Group in the news

B. Braun recalled several lots of IV solutions, including sodium chloride injections, due to contaminants like iron oxide and other particulate matter, posing health risks to patients.

A new lawsuit alleges B. Braun's Hanover Township plant caused cancer and death through ethylene oxide emissions, a claim the company denies.

B. Braun launched a website to defend against lawsuits claiming its ethylene oxide emissions caused cancer, asserting safe operations while plaintiffs' attorneys criticize the defense.

B. Braun Medical Inc. voluntarily recalled a lot of Excel Lactated Ringers Injection due to particulate contamination that could cause serious health issues.

B. Braun Medical Inc. recalled Excel Lactated Ringers Injection due to particulate contamination, which poses serious health risks to patients.

B. Braun Medical Inc. recalled one lot of Excel Lactated Ringers Injection due to particulate matter, posing potential health risks to patients.

Former B. Braun USA Chief Caroll H. Neubauer has joined Butterfly Network's Board of Directors, bringing extensive medical technology and global market experience.

B. Braun has made 7 acquisitions across various sectors and countries, with its most recent being True Digital Surgery, an AI-based surgical instrument provider, in September 2025.

A B. Braun subsidiary is closing two facilities in Pennsylvania, resulting in 173 layoffs, as it strategically shifts its focus from batch sterile compounding to patient-specific compounding.

B. Braun subsidiary CAPS is closing two facilities in Pennsylvania and laying off 173 employees as it exits the 503B sterile compounding business.

B. Braun's subsidiary CAPS is closing two Lehigh County facilities and exiting the 503B sterile compounding business, affecting 173 jobs.

B. Braun UK has promoted Sophie Spencer to social value and ESG specialist to lead sustainability initiatives and social impact reporting.

A new leadership development programme called Beyond Performance has been launched to improve management accountability and team results at B. Braun UK.

B. Braun launched a room-temperature-stable prefilled Rocuronium Bromide syringe to simplify storage and improve clinical efficiency in healthcare facilities.

Former B. Braun CEO Caroll H. Neubauer has joined Butterfly Network's Board of Directors to help scale its ultrasound technology and global market presence.

Former B. Braun CEO Caroll H. Neubauer joins Butterfly Network's board to support the medical imaging firm's global growth and scaling efforts.

B. Braun launched a new room-temperature-stable Rocuronium Bromide prefilled syringe to simplify hospital medication storage and preparation.

Craig Cannings has been promoted to managing director of B. Braun UK to oversee its medical technology, pharmaceutical, and clinical service operations.

Craig Cannings has been promoted to Managing Director of B. Braun UK to oversee national operations and medical technology services.

B. Braun has opened a 60 million euro expanded, carbon-neutral production facility in Melsungen to manufacture automated dialysis machines and infusion pumps for the global market.